Miahelsa Holdings Corporation

¥1,119As of Sun 8 Nov 2026, 12:00 UTC
TSE:7129Healthcare
Country Japan
PE (Fwd) •••
TSR 7Y CAGR 2.98%
Div yield 2.68%
ROE 4.61%
Medical (Pharmaceuticals)
Beta (5Y) 0.08
PE TTM 17.69
TSR TTM 4.76%
Mkt cap ¥3.136B
ROIC 7.26%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1,446
29.23%
7.12%
Hold 0|5|8|11|1
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
11.80
12.86
12.32
11.93
18.74%
18.53%
16.41%
3.06%
Revenue¥M
164.8
159.9
158.5
158.1
9.98%
5.01%
0.83%
(4.60%)
Peers (US$19.91M)
Cap (US$)
PE
36.76M
62.21x
19.24M
54.62x
Capital
TTM
5Y
10Y
Leveragex
1.446
0.057
0.048
EBIT/Intx
5.998
0.328
0.323
Own earn%
(347.49)
(122.11)
(112.24)
Sh yield%
20.90
43.67
40.76
Owners
Insiders/Inst%
2.85
39.23
Short interest%
5.38
SBC / revenue%
2.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
21–26
$1 testx
—
Incr. ROIC%
75